Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis. Arents BWM. Br J Dermatol 2023 Apr 24:ljad068. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Arents BWM. Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis. Br J Dermatol 2023 Apr 24:ljad068. doi: 10.1093.
PMID: 37094084